Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China · Delayed Price · Currency is CNY 18.33
-0.35 (-1.87%)
Jan 23, 2026, 3:13 PM CST
Beijing Scitop Bio-tech Revenue
Beijing Scitop Bio-tech had revenue of 104.04M CNY in the quarter ending September 30, 2025, with 28.98% growth. This brings the company's revenue in the last twelve months to 351.47M, up 16.76% year-over-year. In the year 2024, Beijing Scitop Bio-tech had annual revenue of 302.79M with 1.19% growth.
Revenue (ttm)
351.47M
Revenue Growth
+16.76%
P/S Ratio
13.74
Revenue / Employee
1.19M
Employees
295
Market Cap
4.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 302.79M | 3.55M | 1.19% |
| Dec 31, 2023 | 299.24M | -69.92M | -18.94% |
| Jan 1, 2023 | 369.17M | 4.55M | 1.25% |
| Dec 31, 2021 | 364.62M | 25.46M | 7.51% |
| Dec 31, 2020 | 339.16M | 31.06M | 10.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| ChemPartner PharmaTech | 1.07B |
| Beijing Bohui Innovation Biotechnology Group | 834.38M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Assure Tech (Hangzhou) | 462.72M |
| Innovita Biological Technology | 430.96M |
| Guanhao Biotech | 392.83M |